Merits and complexities of modeling multiple sclerosis in non-human primates: implications for drug discovery
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Merits and complexities of modeling multiple sclerosis in non-human primates: implications for drug discovery
Authors
Keywords
-
Journal
Expert Opinion on Drug Discovery
Volume 13, Issue 5, Pages 387-397
Publisher
Informa UK Limited
Online
2018-02-22
DOI
10.1080/17460441.2018.1443075
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EBV Infection Empowers Human B Cells for Autoimmunity: Role of Autophagy and Relevance to Multiple Sclerosis
- (2017) Elena Morandi et al. JOURNAL OF IMMUNOLOGY
- Of Mice, Dirty Mice, and Men: Using Mice To Understand Human Immunology
- (2017) David Masopust et al. JOURNAL OF IMMUNOLOGY
- Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab
- (2017) Marinella Clerico et al. Multiple Sclerosis Journal
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variants in the IL7RA gene confer susceptibility to multiple sclerosis in Caucasians: evidence based on 9734 cases and 10436 controls
- (2017) Hong Liu et al. Scientific Reports
- Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab
- (2017) Marinella Clerico et al. Multiple Sclerosis Journal
- The role of natalizumab in the treatment of multiple sclerosis: benefits and risks
- (2017) Barry A. Singer Therapeutic Advances in Neurological Disorders
- Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis
- (2017) Cristina Guarnera et al. Therapeutics and Clinical Risk Management
- A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model
- (2017) Bert A. ’t Hart et al. Frontiers in Immunology
- The Cell Biology of Cytomegalovirus: Implications for Transplantation
- (2016) H. Kaminski et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Multiple sclerosis
- (2016) Pierre-Paul Axisa et al. CURRENT OPINION IN NEUROLOGY
- Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010–2015
- (2016) Steffen Pfeuffer et al. Expert Review of Neurotherapeutics
- Lymphocryptovirus Infection of Nonhuman Primate B Cells Converts Destructive into Productive Processing of the Pathogenic CD8 T Cell Epitope in Myelin Oligodendrocyte Glycoprotein
- (2016) S. Anwar Jagessar et al. JOURNAL OF IMMUNOLOGY
- Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study
- (2016) Eva Havrdová et al. JOURNAL OF NEUROLOGY
- The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets
- (2016) Reinhard Hohlfeld et al. LANCET NEUROLOGY
- Normalizing the environment recapitulates adult human immune traits in laboratory mice
- (2016) Lalit K. Beura et al. NATURE
- EBV Infection and Multiple Sclerosis: Lessons from a Marmoset Model
- (2016) Bert A. ‘tHart et al. TRENDS IN MOLECULAR MEDICINE
- Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology?
- (2016) Catherine Larochelle et al. TRENDS IN NEUROSCIENCES
- Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010–2015
- (2016) Steffen Pfeuffer et al. Expert Review of Neurotherapeutics
- “Microglial nodules” and “newly forming lesions” may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out model
- (2015) Fumitaka Sato et al. BMC Neurology
- Mouse Models of Multiple Sclerosis: Lost in Translation?
- (2015) David Baker et al. CURRENT PHARMACEUTICAL DESIGN
- Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis
- (2015) Jordon Dunham et al. Journal of Neuroimmune Pharmacology
- Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund’s adjuvant
- (2015) S. Anwar Jagessar et al. Journal of Neuroinflammation
- Cytomegalovirus: a culprit or protector in multiple sclerosis?
- (2015) Marjan Vanheusden et al. TRENDS IN MOLECULAR MEDICINE
- CD20+ B Cell Depletion Alters T Cell Homing
- (2014) Y. S. Kap et al. JOURNAL OF IMMUNOLOGY
- Digesting the emerging role for the gut microbiome in central nervous system demyelination
- (2014) Jennifer Joscelyn et al. Multiple Sclerosis Journal
- Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis
- (2014) Michael P Pender et al. Multiple Sclerosis Journal
- Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons
- (2013) Shailender Singh et al. ACTA NEUROPATHOLOGICA
- Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple Sclerosis
- (2013) F. Zaguia et al. JOURNAL OF IMMUNOLOGY
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
- (2013) Ashley H Beecham et al. NATURE GENETICS
- Small sample size is not the real problem
- (2013) Peter Bacchetti NATURE REVIEWS NEUROSCIENCE
- The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis
- (2013) Bert A. ‘T Hart et al. Frontiers in Immunology
- B-Cell Depletion Abrogates T Cell-Mediated Demyelination in an Antibody-Nondependent Common Marmoset Experimental Autoimmune Encephalomyelitis Model
- (2012) S. Anwar Jagessar et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis
- (2012) M. Tutuncu et al. Multiple Sclerosis Journal
- Animal models of multiple sclerosis: the good, the bad and the bottom line
- (2012) Richard M Ransohoff NATURE NEUROSCIENCE
- The initiation and prevention of multiple sclerosis
- (2012) Alberto Ascherio et al. Nature Reviews Neurology
- Will the real multiple sclerosis please stand up?
- (2012) Peter K. Stys et al. NATURE REVIEWS NEUROSCIENCE
- Alemtuzumab Therapy for Multiple Sclerosis
- (2012) Alasdair J. Coles Neurotherapeutics
- Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy
- (2011) Jens Ingwersen et al. CLINICAL IMMUNOLOGY
- Treatment of multiple sclerosis with Anti-CD20 antibodies
- (2011) Barbara Barun et al. CLINICAL IMMUNOLOGY
- B-Cell Depletion Attenuates White and Gray Matter Pathology in Marmoset Experimental Autoimmune Encephalomyelitis
- (2011) Yolanda S. Kap et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
- (2011) Kerstin Berer et al. NATURE
- Breaking Free of Sample Size Dogma to Perform Innovative Translational Research
- (2011) P. Bacchetti et al. Science Translational Medicine
- EAE: imperfect but useful models of multiple sclerosis
- (2011) Bert A. ’t Hart et al. TRENDS IN MOLECULAR MEDICINE
- Viral triggers of multiple sclerosis
- (2010) Kristina Kakalacheva et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis
- (2010) C C Walline et al. GENES AND IMMUNITY
- Induction of Progressive Demyelinating Autoimmune Encephalomyelitis in Common Marmoset Monkeys Using MOG34-56Peptide in Incomplete Freund Adjuvant
- (2010) S. Anwar Jagessar et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
- (2010) Robert C Axtell et al. NATURE MEDICINE
- Multiple sclerosis – a response-to-damage model
- (2009) Bert A. ‘t Hart et al. TRENDS IN MOLECULAR MEDICINE
- A Prescription for Human Immunology
- (2008) Mark M. Davis IMMUNITY
- Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE
- (2008) Marloes van Zwam et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis
- (2008) M P Pender et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Autoimmunity Against Myelin Oligodendrocyte Glycoprotein Is Dispensable for the Initiation Although Essential for the Progression of Chronic Encephalomyelitis in Common Marmosets
- (2008) S. Anwar Jagessar et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis
- (2008) Marloes van Zwam et al. JOURNAL OF PATHOLOGY
- Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
- (2008) Benjamin M Segal et al. LANCET NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started